Display Settings:

Format

Send to:

Choose Destination
    Antioxid Redox Signal. 2001 Jun;3(3):451-60.

    Approaches and limitations to gene therapy for mitochondrial diseases.

    Source

    Powell Gene Therapy Center, University of Florida Genetics Institute, Gainesville 32610-0266, USA.

    Abstract

    Mitochondrial dysfunction may be caused by mutations in either the nuclear and/or the mitochondrial genome. Since 1988, mitochondrial DNA mutations have been linked to retinopathies, myopathies, neurodegenerative diseases, and possibly normal aging. Adequate drug therapies for these disorders have yet to be discovered. Therefore, gene therapy must be considered as a possible alternative. In this review, we will discuss the possibilities and the problems associated with gene therapy for mitochondrial disorders.

    PMID:
    11491656
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk